F

Fractyl Health Inc
NASDAQ:GUTS

Watchlist Manager
Fractyl Health Inc
NASDAQ:GUTS
Watchlist
Price: 1.74 USD 2.35% Market Closed
Market Cap: 85.2m USD

Intrinsic Value

GUTS's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one GUTS stock under the Base Case scenario is 1.2 USD. Compared to the current market price of 1.74 USD, Fractyl Health Inc is Overvalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GUTS Intrinsic Value
1.2 USD
Overvaluation 31%
Intrinsic Value
Price
F
Worst Case
Base Case
Best Case

Valuation History
Fractyl Health Inc

Valuation History Unavailable

Historical valuation for GUTS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare GUTS to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about GUTS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Fractyl Health Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Fractyl Health Inc

Current Assets 47m
Cash & Short-Term Investments 42.1m
Other Current Assets 4.9m
Non-Current Assets 36m
PP&E 31.2m
Other Non-Current Assets 4.8m
Efficiency

Free Cash Flow Analysis
Fractyl Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Fractyl Health Inc

Revenue
60k USD
Cost of Revenue
-31k USD
Gross Profit
29k USD
Operating Expenses
-96.8m USD
Operating Income
-96.7m USD
Other Expenses
7.6m USD
Net Income
-89.1m USD
Fundamental Scores

GUTS Profitability Score
Profitability Due Diligence

Fractyl Health Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
ROIC is Increasing
Positive Gross Profit
Negative 1-Year Revenue Growth
23/100
Profitability
Score

Fractyl Health Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

GUTS Solvency Score
Solvency Due Diligence

Fractyl Health Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
27/100
Solvency
Score

Fractyl Health Inc's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GUTS Price Targets Summary
Fractyl Health Inc

Wall Street analysts forecast GUTS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GUTS is 9.52 USD with a low forecast of 6.06 USD and a high forecast of 12.6 USD.

Lowest
Price Target
6.06 USD
248% Upside
Average
Price Target
9.52 USD
447% Upside
Highest
Price Target
12.6 USD
624% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Fractyl Health Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for GUTS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

GUTS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one GUTS stock?

The intrinsic value of one GUTS stock under the Base Case scenario is 1.2 USD.

Is GUTS stock undervalued or overvalued?

Compared to the current market price of 1.74 USD, Fractyl Health Inc is Overvalued by 31%.

Back to Top